Latest Royalty Income News

Opthea Limited reported a 26% reduction in net loss for FY2025 despite discontinuing its wet AMD drug after failed Phase III trials. The company settled its Development Funding Agreement with investors, securing liquidity and planning a strategic pivot.

Cambium Bio reported a $3.84 million loss for FY25 but secured critical FDA approvals and ethics clearances to initiate Phase 3 trials of Elate Ocular®, supported by a $2.12 million capital raise.

Anagenics has delivered a significant financial turnaround in FY25, driven by a strategic restructure, exiting loss-making operations, and securing new royalty agreements. Despite a revenue dip, the company improved profitability and cash flow, positioning itself for sustainable growth.

Weebit Nano Limited reported a strong FY25 with revenues surging over fourfold to $4.4 million and a narrowed net loss of $38.4 million, driven by key licensing deals and progress towards automotive-grade ReRAM qualification.

Neuren Pharmaceuticals reported a robust half-year with an 88% increase in net profit, driven by rising royalties from DAYBUE™ sales and progress in its NNZ-2591 clinical program. The company also completed a $39.6 million share buy-back, underscoring confidence in its growth trajectory.

Neuren Pharmaceuticals reports a 16% rise in Q2 2025 royalties driven by Acadia’s DAYBUE sales growth and expanding patient base in the US. Full-year sales guidance remains strong with European market entry on the horizon.

GWR Group Limited reports steady progress on its Prospect Ridge magnesium project with ongoing metallurgical testing and a strong cash position of $38 million. The company also revises Wiluna iron ore royalty terms and pursues strategic acquisitions.

Ragnar Metals reported a cash outflow for the June quarter, leaving just over one quarter of funding available, yet it remains optimistic about upcoming royalty income and future financing.

High Peak Royalties Limited reported stable royalty receipts of A$345,240 for the June 2025 quarter, maintaining cash flow while advancing monitoring of key gas and geothermal assets across Australia and the US.

Hawthorn Resources is progressing its Anglo Saxon gold project with an approved drilling program and advancing mining lease applications at Mt Bevan, while maintaining a strong cash position.

Tombador Iron Limited reported a solid cash position of AUD 9.549 million as it advances the acquisition of the Colomi Iron Project in Brazil, while navigating royalty income challenges and preparing for a capital raise.

Red Hill Minerals reported robust royalty revenues and exploration progress in the June 2025 quarter, underpinned by strong iron ore shipments and strategic royalty acquisitions. The company’s solid cash position and advancing drill programs position it well for growth.